Ford Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-2,569
Closed -$151K – 388
2021
Q4
$151K Buy
+2,569
New +$127K 0.03% 121
2021
Q3
– Sell
-2,896
Closed -$113K – 412
2021
Q2
$113K Buy
+2,896
New +$113K 0.04% 146
2018
Q1
– Sell
-824
Closed -$28K – 282
2017
Q4
$28K Buy
+824
New +$28.1K 0.02% 128

Other funds holding PFE

Ford Financial Group's PFE Position: Q1 2022 in Review

Ford Financial Group sold out of Pfizer (PFE) in Q1 2022, closing a stake of 2,569 shares — an estimated $151K sold.

Ford Financial Group first reported a position in PFE in Q4 2017 and held it in 3 quarters. The position peaked at $151K in Q4 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • Ford Financial Group reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
  • Ford Financial Group sold 2,569 Pfizer shares in Q1 2022, an estimated $151K.
  • Ford Financial Group first reported a position in Pfizer in Q4 2017 and held it in 3 quarters.
  • Ford Financial Group's Pfizer position peaked at $151K in Q4 2021.
  • 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Ford Financial Group's 13F filing for Q1 2022, filed 13 Apr 2022.